March 11, 2010 (FinancialWire) — 3SBio Inc. (NASDAQ: SSRX), a chinese biotechnology firm, said that Liping Xu, the firm’s executive director and vice president, will retire from its board and her position as a company officer for health reasons, effective March 10. Xu was one of the founders of the company.

She and has been a director of 3SBio and its predecessor company, Shenyang Sunshine, since 1993.

Concurrently, effective March 10, Peiguo Cong will join the board and serve as an independent, non-executive director. Cong has been the managing partner of Beijing Jun You law firm since 1994. He also currently serves as a member of the financial securities committee of the China National Lawyers Association, member of the All China Federation of Industry and Commerce, director of the Chinese Society of Mergers and acquisitions, independent committee member of the Credit Committee of the National Development Bank, and part-time professor at Peking University.

China-based 3SBio is focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China.

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.